ScopeGreat Ormond Street Hospital for Children NHS Foundation Trust
88 capabilities
Verified Sep 2026
One of 2,380 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Haematology Department, (Haematology and Blood Transfusion, SIHMDS), Level 1 Camelia Botnar Laboratories, Great Ormond Street Hospital
London WC1N 3JH , United Kingdom
London WC1N 3JH , United Kingdom
Accreditation
Active
UKAS
8623
gosh.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8623
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Great Ormond Street Hospital for Children NHS Foundation Trust
37 Queen Square
Great Ormond Street Hospital for Children NHS Foundation Trust
London
Great Ormond Street Hospital for Children NHS Foundation Trust
London
Great Ormond Street Hospital for Children NHS Foundation Trust
Camelia Botnar Laboratories
Great Ormond Street Hospital for Children NHS Foundation Trust
Camelia Botnar Laboratories
Great Ormond Street Hospital for Children NHS Foundation Trust
Camelia Botnar Laboratories
Great Ormond Street Hospital for Children NHS Foundation Trust
London
Test Capabilities (88)
| Standard Reference | Description | Category |
|---|---|---|
| Coagulation screen: | Photometric end-point clot | Coagulation screen: | Photometric end-point clot | Clinical Chemistry |
| D Dimers | HSOP 109 | D Dimers | HSOP 109 | Clinical Chemistry |
| D Dimers | Latex Immunoassay | D Dimers | Latex Immunoassay | Clinical Chemistry |
| Whole blood (EDTA) Glucose-6-Phosphate (G6PD) | Enzymecolorimetric method | Whole blood (EDTA) Glucose-6-Phosphate (G6PD) | Enzymecolorimetric method | Clinical Chemistry |
| Whole blood (EDTA) Glucose-6-Phosphate (G6PD) | HSOP 264 | Whole blood (EDTA) Glucose-6-Phosphate (G6PD) | HSOP 264 | Clinical Chemistry |
| Whole blood (EDTA) Glucose-6-Phosphate (G6PD) | Pointe Scientific Kit | Whole blood (EDTA) Glucose-6-Phosphate (G6PD) | Pointe Scientific Kit | Clinical Chemistry |
| Plasmodium +/-Falciparum (HRP | 2 ) assay | Plasmodium +/-Falciparum (HRP | 2 ) assay | Clinical Microbiology |
| Activated Protein C Resistance | Clotting assay HSOP 148 | Activated Protein C Resistance | Clotting assay HSOP 148 | Hematology |
| All2gether trial | FSOP 524 ALL2gether Trial Flow | All2gether trial | FSOP 524 ALL2gether Trial Flow | Hematology |
| All2gether trial | MRD Quantification | All2gether trial | MRD Quantification | Hematology |
| Alpha 2 antiplasmin | Chromogenic assay HSOP 133 | Alpha 2 antiplasmin | Chromogenic assay HSOP 133 | Hematology |
| Antithrombin Activity | HSOP 148 | Antithrombin Activity | HSOP 148 | Hematology |
| Antithrombin Antigen | HSOP 148 | Antithrombin Antigen | HSOP 148 | Hematology |
| Binding Assay (vW:CBA) | ELISA read on | Binding Assay (vW:CBA) | ELISA read on | Hematology |
| Blood Red cell membrane defects by | Becton Dickinson FACSCanto II 3 | Blood Red cell membrane defects by | Becton Dickinson FACSCanto II 3 | Hematology |
| Blood Red cell membrane defects by | Eosin-5-Maleimide (E5M) Dye | Blood Red cell membrane defects by | Eosin-5-Maleimide (E5M) Dye | Hematology |
| Bone Marrow | 780 | Bone Marrow | 780 | Hematology |
| Bone marrow B-Cell Precursor Acute | 8 Colour BD FACS Canto II x 2 | Bone marrow B-Cell Precursor Acute | 8 Colour BD FACS Canto II x 2 | Hematology |
| CSF/Body fluid/peritoneal, pleural White Cell Count, Red Cell Count | XN-2000, HSOP 207 and 214 | CSF/Body fluid/peritoneal, pleural White Cell Count, Red Cell Count | XN-2000, HSOP 207 and 214 | Hematology |
| Factor VIII | Chromogenic assay | Factor VIII | Chromogenic assay | Hematology |
| Factor XIII | HSOP 120 | Factor XIII | HSOP 120 | Hematology |
| Free Protein S Antigen | HSOP 148 | Free Protein S Antigen | HSOP 148 | Hematology |
| Heparin Anti Xa activity | HSOP 109 | Heparin Anti Xa activity | HSOP 109 | Hematology |
| Inhibitor Assays - FVIII, FIX | HSOP 127 | Inhibitor Assays - FVIII, FIX | HSOP 127 | Hematology |
| Lupus Anticoagulant Screen by | DRVVT HSOP 137 | Lupus Anticoagulant Screen by | DRVVT HSOP 137 | Hematology |
| Mean Cell Haemoglobin (MCH) | HSOP 204A & HSOP 208 | Mean Cell Haemoglobin (MCH) | HSOP 204A & HSOP 208 | Hematology |
| Panel for patients enrolled on the | BCP-ALL MRD7 Cytognos Kits | Panel for patients enrolled on the | BCP-ALL MRD7 Cytognos Kits | Hematology |
| Plasminogen | Chromogenic assay HSOP 133 | Plasminogen | Chromogenic assay HSOP 133 | Hematology |
| Protein C Activity | Chromogenic assay HSOP 148 | Protein C Activity | Chromogenic assay HSOP 148 | Hematology |
| Von Willebrand Factor antigen, | HSOP 128 | Von Willebrand Factor antigen, | HSOP 128 | Hematology |
| Whole Blood (Citrate) Platelet function (PFA) | HSOP 134 | Whole Blood (Citrate) Platelet function (PFA) | HSOP 134 | Hematology |
| Whole Blood (EDTA) Erythrocyte Sedimentation Rate | HSOP 216 – manual method | Whole Blood (EDTA) Erythrocyte Sedimentation Rate | HSOP 216 – manual method | Hematology |
| Whole Blood (EDTA) Erythrocyte Sedimentation Rate | P4 Westergren Kits manufactured | Whole Blood (EDTA) Erythrocyte Sedimentation Rate | P4 Westergren Kits manufactured | Hematology |
| Whole Blood (EDTA) Full blood counts and automated | Sysmex XN2000 | Whole Blood (EDTA) Full blood counts and automated | Sysmex XN2000 | Hematology |
| Whole Blood (EDTA) Sickle Solubility test for presence of | HSOP 220 Sickle Solubility Test | Whole Blood (EDTA) Sickle Solubility test for presence of | HSOP 220 Sickle Solubility Test | Hematology |
| Whole Blood (EDTA) Staining and examination of | FSOP 470. | Whole Blood (EDTA) Staining and examination of | FSOP 470. | Hematology |
| Biopsy Neuroblastoma Panel – by | FSOP492 ,FSOP489, HSOP490 | Biopsy Neuroblastoma Panel – by | FSOP492 ,FSOP489, HSOP490 | Histopathology / Cytology |
| Bone marrow Staining and examination of bone | HSOP 210 Staining of Bone | Bone marrow Staining and examination of bone | HSOP 210 Staining of Bone | Histopathology / Cytology |
| Cytological abnormalities for the | HQU 016 Clinical Reporting Policy | Cytological abnormalities for the | HQU 016 Clinical Reporting Policy | Histopathology / Cytology |
| Unstained slides | Spectrophotometer | Unstained slides | Spectrophotometer | Histopathology / Cytology |
| ABO Isohaemagglutinins (IgG/IgM) | 500 | ABO Isohaemagglutinins (IgG/IgM) | 500 | Immunology / Serology |
| ABO Isohaemagglutinins (IgG/IgM) | HSOP 312 | ABO Isohaemagglutinins (IgG/IgM) | HSOP 312 | Immunology / Serology |
| Anti-A IgM immunoglobulin | HSOP 312 | Anti-A IgM immunoglobulin | HSOP 312 | Immunology / Serology |
| Blood CD66abce expression | FSOP485, FSOP489, HSOP490 | Blood CD66abce expression | FSOP485, FSOP489, HSOP490 | Immunology / Serology |
| Blood Intracellular Marker Expression | HSOP418, FSOP489, HSOP490 | Blood Intracellular Marker Expression | HSOP418, FSOP489, HSOP490 | Immunology / Serology |
| Blood NG2 expression | HSOP416 ,FSOP489, HSOP490 | Blood NG2 expression | HSOP416 ,FSOP489, HSOP490 | Immunology / Serology |
| Blood Platelet Glycoproteins | HSOP427, FSOP489, HSOP490 | Blood Platelet Glycoproteins | HSOP427, FSOP489, HSOP490 | Immunology / Serology |
| Blood Quantification of Paroxysmal | HSOP488, FSOP489, HSOP490 | Blood Quantification of Paroxysmal | HSOP488, FSOP489, HSOP490 | Immunology / Serology |
| Bone marrow Disease (MRD) in Myeloid and | HSOP490 and HSOP491 | Bone marrow Disease (MRD) in Myeloid and | HSOP490 and HSOP491 | Immunology / Serology |
| C,E,c,e,Cw,K, | IH-500 and HSOP 308 | C,E,c,e,Cw,K, | IH-500 and HSOP 308 | Immunology / Serology |
| D,C,E,c,e,Cw,K,k,Kpa,Kpb,Fya,Fyb, | HSOP 306 | D,C,E,c,e,Cw,K,k,Kpa,Kpb,Fya,Fyb, | HSOP 306 | Immunology / Serology |
| HUMAN TISSUE AND FLUIDS Immunophenotyping examinations | II 3 laser flow cytometer or BD | HUMAN TISSUE AND FLUIDS Immunophenotyping examinations | II 3 laser flow cytometer or BD | Immunology / Serology |
| IgM heterophile antibodies | 221 Chromatographic | IgM heterophile antibodies | 221 Chromatographic | Immunology / Serology |
| Jka,Jkb,Lea,Leb,P1,M,N,S,s,Lua, | Bio-Rad IH-500 | Jka,Jkb,Lea,Leb,P1,M,N,S,s,Lua, | Bio-Rad IH-500 | Immunology / Serology |
| Pericardial fluid • | Lymphoid phenotyping HSOP490 and HSOP491 | Pericardial fluid • | Lymphoid phenotyping HSOP490 and HSOP491 | Immunology / Serology |
| Serological Crossmatch - | HSOP307 | Serological Crossmatch - | HSOP307 | Immunology / Serology |
| Whole blood (EDTA) Antibody screening and | HSOP 306 | Whole blood (EDTA) Antibody screening and | HSOP 306 | Immunology / Serology |
| Whole blood (EDTA) Blood grouping by antigen | 331, 331C | Whole blood (EDTA) Blood grouping by antigen | 331, 331C | Immunology / Serology |
| Whole blood (EDTA) Blood grouping by antigen | • ABO/D blood groups Bio-Rad IH-500 | Whole blood (EDTA) Blood grouping by antigen | • ABO/D blood groups Bio-Rad IH-500 | Immunology / Serology |
| Whole blood (EDTA) Blood grouping by antigen | • ABO/D blood groups HSOP 305 | Whole blood (EDTA) Blood grouping by antigen | • ABO/D blood groups HSOP 305 | Immunology / Serology |
| Whole blood (EDTA) Compatibility Testing: | Diamed Gel cards using | Whole blood (EDTA) Compatibility testing: | Automated Ortho Swift analyser | Immunology / Serology |
| Whole blood (EDTA) Direct Antiglobulin Test (DAT) | IH-500 and HSOP319 | Whole blood (EDTA) Direct Antiglobulin Test (DAT) | IH-500 and HSOP319 | Immunology / Serology |
| Blood (CAR T) | (Bio-Rad) Bio-Rad C1000 Touch | Blood (CAR T) | (Bio-Rad) Bio-Rad C1000 Touch | Molecular Diagnostics / PCR |
| Blood (CAR T) | 100%. Using Bio-Rad QX200 Auto | Blood (CAR T) | 100%. Using Bio-Rad QX200 Auto | Molecular Diagnostics / PCR |
| Blood (CAR T) | Plate Reader and SOP ASOP 117 | Blood (CAR T) | Plate Reader and SOP ASOP 117 | Molecular Diagnostics / PCR |
| Blood (CAR T) | Thermal Cycler Bio-Rad QX200 | Blood (CAR T) | Thermal Cycler Bio-Rad QX200 | Molecular Diagnostics / PCR |
| DNA Chimerism genotyping | HSOP 791 and FSOP 49 | DNA Chimerism genotyping | HSOP 791 and FSOP 49 | Molecular Diagnostics / PCR |
| DNA Chimerism genotyping | Using G-storm 4 and Proflex | DNA Chimerism genotyping | Using G-storm 4 and Proflex | Molecular Diagnostics / PCR |
| Leiden and Prothrombin Variant | HSOP444 | Leiden and Prothrombin Variant | HSOP444 | Molecular Diagnostics / PCR |
| Sorted cells from blood (EDTA) Quantification of T cell receptor | 466 (Spectratyping Guidelines). | Sorted cells from blood (EDTA) Quantification of T cell receptor | 466 (Spectratyping Guidelines). | Molecular Diagnostics / PCR |
| Sorted cells from blood (EDTA) Quantification of T cell receptor | Fragment analysis HSOP 468 | Sorted cells from blood (EDTA) Quantification of T cell receptor | Fragment analysis HSOP 468 | Molecular Diagnostics / PCR |
| Sorted cells from blood (EDTA) Quantification of T cell receptor | Polymerase, G Storm 4 PCR | Sorted cells from blood (EDTA) Quantification of T cell receptor | Polymerase, G Storm 4 PCR | Molecular Diagnostics / PCR |
| Sorted cells from blood (EDTA) Quantification of T cell receptor | RT-PCR using HSOP 467 | Sorted cells from blood (EDTA) Quantification of T cell receptor | RT-PCR using HSOP 467 | Molecular Diagnostics / PCR |
| TCRE DNA from cells sorted from Thymic T-cell recovery | HSOP 482 TRECs part 2 - qPCR | TCRE DNA from cells sorted from Thymic T-cell recovery | HSOP 482 TRECs part 2 - qPCR | Molecular Diagnostics / PCR |
| 1 – 5 logs). | ALL MRD Control Gene Analysis | 1 – 5 logs). | ALL MRD Control Gene Analysis | Other |
| 1 – 5 logs). | Design and Ordering of ASO | 1 – 5 logs). | Design and Ordering of ASO | Other |
| 1 – 5 logs). | PCR HSOP 501. | 1 – 5 logs). | PCR HSOP 501. | Other |
| 1 – 5 logs). | PCR for ALLtogether trial (A2G) | 1 – 5 logs). | PCR for ALLtogether trial (A2G) | Other |
| ALL) Flow MRD quantification using | R33896202743) | ALL) Flow MRD quantification using | R33896202743) | Other |
| Blood / Unstained slides as defined by (number of cells | HSOP 805 | Blood / Unstained slides as defined by (number of cells | HSOP 805 | Other |
| Blood Lymphoblastic Leukaemia (BCP- | (S/N V96300806 and | Blood Lymphoblastic Leukaemia (BCP- | (S/N V96300806 and | Other |
| Differential: | Coulter Cellular analysis System | differential: | Fluorescence flow cytometry, | Other |
| Heparin) Screen | HSOP 263 | Heparin) Screen | HSOP 263 | Other |
| Leiden and Prothrombin Variant | Master Mix (2X) (No AmpErsae | Leiden and Prothrombin Variant | Master Mix (2X) (No AmpErsae | Other |
| Leiden and Prothrombin Variant | UNG), TaqMan 7500 Fast PCR | Leiden and Prothrombin Variant | UNG), TaqMan 7500 Fast PCR | Other |
| Plasmodium +/-Falciparum (HRP | HSOP 213 | Plasmodium +/-Falciparum (HRP | HSOP 213 | Other |
| Sorted cells from blood (EDTA) Quantification of T cell receptor | 3500xl Genetic Analyser (FSOP | Sorted cells from blood (EDTA) Quantification of T cell receptor | 3500xl Genetic Analyser (FSOP | Other |
| Sorted cells from blood (EDTA) Quantification of T cell receptor | 491). | Sorted cells from blood (EDTA) Quantification of T cell receptor | 491). | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.